Actinium Pharmaceuticals (ATNM)
(Delayed Data from AMEX)
$1.82 USD
+0.05 (2.82%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $1.80 -0.02 (-1.10%) 6:54 PM ET
3-Hold of 5 3
F Value D Growth A Momentum F VGM
Brokerage Reports
0 items in cart
Actinium Pharmaceuticals, Inc. [ATNM]
Reports for Purchase
Showing records 61 - 80 ( 97 total )
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Following the Paths That Make Sense; NIH Links up Actinium With MSKCC
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Pipeline Visibility Increasing as We Await SIERRA; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Critical Time Approaching Quickly; SIERRA Ad Hoc Exercised; PT Adjusted to $65 Post Reverse Split
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
We are initiating coverage with a Buy rating and $3 price target.
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
We are dropping coverage of ATNM shares due to the departure of the covering analyst.
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare -New Leukemia Approvals - Their Implications
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Dropping Coverage
Provider: H.C. Wainwright & Co., Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Healthcare - ORD-ARN-JFK: Crossing Our Onco Radar
Provider: Roth Capital Partners, Inc.
Analyst: MARANGO J
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Actinium Pharmaceuticals, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.